Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
TheStreet.com
Thu, 07/27/17 - 11:56 am
Tags:
AstraZeneca, Mystic, clinical trials, M&A, Pfizer, Merck
AstraZeneca Cancer Drug Failure Doesn't Bode Well For Bristol Myers
TheStreet.com
Thu, 07/27/17 - 11:07 am
Tags:
AstraZeneca, clinical trials, Mystic, Bristol-Myers Squibb, Opdivo
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
Stat
Thu, 07/27/17 - 09:59 am
Tags:
AstraZeneca, Mystic, immuno-oncology, clinical trials, tremelimumab, Imfinzi
These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now
Motley Fool
Wed, 07/26/17 - 11:22 am
Tags:
Pfizer, M&A, AstraZeneca, Bristol-Myers Squibb
AstraZeneca CEO reassures staff, aims to be at September cancer meet
Reuters
Fri, 07/21/17 - 11:27 am
Tags:
AstraZeneca, Pharma CEOs, Pascal Soriot, Teva Pharmaceutical
5 Big Pharma Stocks With the Best Drug Pipelines
Motley Fool
Tue, 07/18/17 - 11:32 am
Tags:
Big Pharma, Roche, AstraZeneca, AbbVie, Gilead Sciences, JNJ
Will he stay or will he go? AZ's shares jump, Teva's sink on report that Soriot will stay put
Fierce Pharma
Fri, 07/14/17 - 03:46 pm
Tags:
AstraZeneca, Pascal Soriot, Teva Pharmaceutical, Pharma CEOs
Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says
Fierce Pharma
Thu, 07/13/17 - 09:33 pm
Tags:
PARP inhibitors, AstraZeneca, Clovis Oncology, Tesaro, drug pricing
Soriot skipping over to Teva ahead of MYSTIC results?
BioPharma Dive
Thu, 07/13/17 - 05:36 pm
Tags:
Pascal Soriot, AstraZeneca, Pharma CEOs, Teva Pharmaceutical, tremelimumab
Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
Endpoints
Thu, 07/13/17 - 08:53 am
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs, Teva Pharmaceutical
AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report
Reuters
Wed, 07/12/17 - 04:27 pm
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs, Teva Pharmaceutical
AstraZeneca Expects Brilinta to Become a Blockbuster Therapy in 2017
Market Realist
Wed, 07/12/17 - 10:01 am
Tags:
AstraZeneca, Brilinta
What the FDA's Hold on Three Merck Studies Means for Other Drug Makers
TheStreet.com
Sun, 07/9/17 - 07:44 pm
Tags:
Merck, Keytruda, FDA, clinical trials, Multiple Myeloma, Bristol-Myers Squibb, AstraZeneca, Celgene
Ex-AstraZeneca executive Luke Miels accuses CEO Soriot of threatening him for taking GSK job
Fierce Pharma
Thu, 07/6/17 - 09:48 am
Tags:
Pascal Soriot, Pharma CEOs, Luke Miels, GSK, AstraZeneca
AstraZeneca Expected to Report Fall in Revenues in 2017
Market Realist
Mon, 07/3/17 - 09:44 am
Tags:
AstraZeneca, earnings
Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom
Endpoints
Thu, 06/29/17 - 09:23 am
Tags:
investors, AstraZeneca, Pascal Soriot, Imfinzi, tremelimumab, immuno-oncology, clinical trials
AstraZeneca's struggling FluMist loses out on crucial CDC vaccine backing—again
Fierce Pharma
Tue, 06/27/17 - 11:48 pm
Tags:
AstraZeneca, FluMist, CDC, vaccines
Pfizer Fueling Growth Of Competitors' Pipelines
Forbes
Tue, 06/27/17 - 10:02 am
Tags:
Pfizer, R&D, Clovis Oncology, Puma Biotechnology, Bioventus, Shire, AstraZeneca
AstraZeneca at Cannes: Healthcare delivery's speeding away from pharma's marketing model
Fierce Pharma
Mon, 06/26/17 - 11:57 am
Tags:
AstraZeneca, pharma marketing
For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand
FOX Business
Tue, 06/20/17 - 09:41 am
Tags:
AstraZeneca, Mystic, lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.